Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CALT

China launches new set of classified Yaogan spy satellites (video)

A Long March 2C rocket launched three Yaogan-43 spy satellites to orbit from southwestern China on Oct. 22, marking the third liftoff of the mysterious satellite series.

Space

China prepares for 1st launch of new Long March 8A rocket

China's new Long March 8A rocket could fly for the first time by the end of the year, helping the country build a number of planned satellite megaconstellation.

Space

3 Pharma Gems Poised for Breakthroughs

The pharmaceutical industry is rapidly expanding, fueled by continued R&D efforts leading to the discovery of new drugs and therapies, biotechnology innovations, and growing medical needs. Thus, let’s take a look at pharma gems Pacira BioSciences (PCRX), Calliditas Therapeutics (CALT), and Astellas Pharma (ALPMY) poised for breakthroughs. Read more….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

China Boots Former Aerospace Academy Head From Political Advisory Body

Wang Xiaojun, ex-president of the China Academy of Launch Vehicle Technology, is the latest in a string of arms and aerospace executives ousted from the CPPCC

Caixin Global

Which of these 3 Pharma Stocks Should You Buy, Hold or Sell?

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. So, let's analyze whether Johnson & Johnson (JNJ), Calliditas Therapeutics AB (CALT), and Aurora Cannabis (ACB) are a Buy, Hold, or Sell.

StockNews.com

3 Pharma Stocks to Add to Your June Watchlist

The pharmaceutical industry is growing amid the adoption of enhanced technologies such as AI and new drug discoveries. Given the industry’s long-term solid prospects, pharma stocks Sanofi (SNY), Takeda Pharmaceutical (TAK), and Calliditas Therapeutics (CALT) could be worth adding to your watchlist. Read on.

StockNews.com

2 Pharma Stocks Investors Are Flocking

The pharmaceutical industry is expected to thrive amid robust demand and government support. Given the solid long-term prospects of the industry, investors should consider buying pharma stocks Ironwood Pharmaceuticals (IRWD) and Calliditas Therapeutics (CALT). Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Calliditas' Kinpeygo Receives CHMP Backing For Kidney Disease

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional approval for Calliditas Therapeutics AB's (NASDAQ:CALT) Kinpeygo for primary immunoglobulin A (IgA) nephropathy (IgAN). The opinion covers adult patients at risk of rapid disease progression with a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/gram. Also See: Calliditas…

Benzinga

Calliditas Expects EMA's CHMP Opinion For Nefecon In Q2

Calliditas Therapeutics AB (NASDAQ:CALT) says that the opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) can be expected in Q2 of 2022. In its review of the marketing authorization application (MAA) for Nefecon, the CHMP has informed us that they will issue an…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

125 stories

European Medicines Agency

Takeda Pharmaceutical Company Limited

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.